Investors often overlook companies that report late in the year, but their disclosures are well worth perusing as a guide to corporate health.

Sampling has stretched polymetallic mineralisation along the Blue Dick Trend to about 3km at Mammoth’s (ASX:M79) Excelsior ...

An MOU between LU7 and Taiwan’s RePV Tech is aimed at recovering high-purity silver from recycled solar cells and PV waste.

Lotus Resources could be the value play in ASX uranium developers as the broader market ignores yellowcake's nuclear ...

The ASX healthcare sector fell for the week ending November 7, 2025, but several names have bucked the trend on positive news ...

The ASX 200 shed 0.66pc today, led lower by weakness in info tech and the big banks as investors rotated into defensive ...

Canaccord Genuity analysts have lifted near and long term price forecasts for key rare earth metals thanks to floor prices ...

EMVision CEO and managing director Scott Kirkland reflects on what has been a big year, with the medtech steadily achieving ...

From midnight flights to $600 champagne splurges, The Australian’s frequent-flyer readers share the lengths they’ll go to for ...

ASX device and diagnostic companies are intensifying their measures to expedite product rollouts and approvals in the US.

Gallium prices have become prone to price shocks thanks to Chinese export controls, creating the perfect storm of this ASX ...

Renascor Resources (ASX:RNU) gets the go ahead to start drilling near-surface copper, cobalt and gold targets at Bulloo Creek ...